GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AlzeCure Pharma ALZCUR.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

6.46

+5.56%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2017FY2025

Net income

−SEK 47.7m

FY2017FY2025

Free cash flow

−SEK 34.6m

FY2017FY2025

Shareholders' equity

SEK 32.9m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue————————SEK 883,385
Gross profit−SEK 1.3m−SEK 293,000−SEK 476,000−SEK 570,000−SEK 576,000−SEK 495,000−SEK 44.8m−SEK 104,000SEK 875,385
Research and developmentSEK 36.2mSEK 24.7mSEK 27.2mSEK 46.2mSEK 66.7mSEK 62.4mSEK 44.8mSEK 36.8mSEK 11.0m
Operating income−SEK 49.4m−SEK 36.5m−SEK 38.3m−SEK 56.4m−SEK 77.9m−SEK 71.6m−SEK 50.9m−SEK 36.1m−SEK 10.8m
Net income−SEK 47.7m−SEK 35.2m−SEK 37.2m−SEK 56.0m−SEK 77.8m−SEK 71.4m−SEK 51.0m−SEK 36.0m−SEK 10.8m
Diluted earnings per share-0.41-0.40-0.60-1.10-1.75-1.80-1.29-0.92-0.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsSEK 59.0mSEK 34.4mSEK 32.0mSEK 70.8mSEK 45.6mSEK 117.8mSEK 186.8mSEK 237.8mSEK 56.0m
Cash and short-term investmentsSEK 50.3mSEK 31.5mSEK 29.1mSEK 25.6mSEK 41.7mSEK 112.4mSEK 182.5mSEK 234.5mSEK 54.0m
Total liabilitiesSEK 26.1mSEK 8.3mSEK 8.2mSEK 10.4mSEK 12.7mSEK 7.1mSEK 4.7mSEK 4.6mSEK 4.1m
DebtSEK 5.1mSEK 3.6m—————−SEK 400,000−SEK 1.8m
Shareholders' equitySEK 32.9mSEK 26.2mSEK 23.8mSEK 60.5mSEK 33.0mSEK 110.8mSEK 182.0mSEK 233.2mSEK 51.8m
Shares outstanding115m88m62m51m44m40m39m39m24m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−SEK 34.6m−SEK 35.1mSEK 3.1m−SEK 99.9m−SEK 70.6m−SEK 69.5m−SEK 50.3m−SEK 36.3m−SEK 8.4m
Capital spending—−SEK 124,000——−SEK 54,000−SEK 671,000−SEK 1.5m−SEK 459,000−SEK 267,000
Free cash flow−SEK 34.6m−SEK 35.2mSEK 3.1m−SEK 99.9m−SEK 70.7m−SEK 70.2m−SEK 51.7m−SEK 36.7m−SEK 8.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 97.3m———————
Gross profitSEK 97.3m−SEK 301,000−SEK 301,000−SEK 313,000−SEK 31,000−SEK 43,000−SEK 51,000−SEK 64,000
Operating incomeSEK 76.9m−SEK 24.0m−SEK 19.0m−SEK 10.1m−SEK 9.8m−SEK 10.2m−SEK 9.6m−SEK 7.8m
Net incomeSEK 80.2m−SEK 21.7m−SEK 17.7m−SEK 10.0m−SEK 9.7m−SEK 10.1m−SEK 9.3m−SEK 7.4m
Diluted earnings per share0.58-0.16-0.15-0.09-0.08-0.09-0.11-0.08
Cash from operations−SEK 19.0m−SEK 17.0m−SEK 16.0m−SEK 7.0m—−SEK 10.0m−SEK 7.0m−SEK 8.0m
Total assetsSEK 122.4mSEK 40.8mSEK 59.0mSEK 66.6mSEK 16.4mSEK 24.7mSEK 34.4mSEK 42.6m
Cash and short-term investmentsSEK 13.5mSEK 33.0mSEK 50.3mSEK 59.2mSEK 12.6mSEK 20.8mSEK 31.5mSEK 39.2m
Debt——SEK 2.6mSEK 2.8m————
Shareholders' equitySEK 91.4mSEK 11.2mSEK 32.9mSEK 50.7mSEK 6.3mSEK 16.1mSEK 26.2mSEK 35.5m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-4.4%-7.2%—
Net income-5.3%-7.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-4.8-2.9-3.4-2.4-2.1-3.1-2.0-3.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.